Taipei Exchange - Delayed Quote TWD
TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)
9.52
+0.11
+(1.17%)
As of 10:09:38 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-173,088
-173,088
7,459
-21,269
629,069
Investing Cash Flow
-110,872
-110,872
145,461
-84,953
-306,069
Financing Cash Flow
-17,400
-17,400
-21,123
-15,841
-18,849
End Cash Position
74,136
74,136
374,655
243,109
364,931
Capital Expenditure
-2,696
-2,696
-7,394
-7,464
-11,832
Issuance of Debt
--
--
-3,000
3,000
--
Repayment of Debt
--
--
-3,000
--
--
Free Cash Flow
-175,784
-175,784
65
-28,733
617,237
12/31/2021 - 8/30/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4168.TWO GlycoNex Incorporation
16.35
+1.55%
4167.TWO Savior Lifetec Corporation
18.20
+1.96%
3176.TWO Medigen Biotechnology Corp.
29.20
+1.04%
4726.TWO Mycenax Biotech Inc.
30.90
+1.15%
4174.TWO OBI Pharma, Inc.
38.00
-9.95%
4743.TWO Oneness Biotech Co., Ltd.
62.00
+2.82%
4162.TWO PharmaEngine, Inc.
88.80
+1.25%
4147.TWO TaiMed Biologics Inc.
80.60
+1.26%
4142.TW Adimmune Corporation
18.35
+1.10%
4130.TWO Genovate Biotechnology Co., Ltd.
20.35
+0.99%